+22 22 0
Published 2 years ago by grandtheftsoul with 0 Comments
by grandtheftsoul
2 years ago

Doctors Gene-Edit Patient's Liver to Make Less Cholesterol

A team of researchers from US biotech company Verve Therapeutics have injected a gene-editing serum into a live patient's liver with the goal of lowering their cholesterol, a watershed moment in the history of gene editing that could potentially save millions from cardiovascular disease and heart attacks, MIT Technology Review reports.

Continue Reading https://futurism.com

Join the Discussion

  • Auto Tier
  • All
  • 1
  • 2
  • 3
Post Comment

Here are some other snaps you may like...

discover your
interests.

Check out our front page for a lot more stuff!

The first CRISPR gene-editing drug is coming—possibly as soon as next year

CRISPR, 10 Years On: Learning to Rewrite the Code of Life

Next up for CRISPR: Gene editing for the masses?

A bold effort to cure HIV—using Crispr

Statin therapy is not warranted for a person with high... : Current Opinion in Endocrinology, Diabetes and Obesity